Header Logo

Connection

Bette Caan to Comorbidity

This is a "connection" page, showing publications Bette Caan has written about Comorbidity.
Connection Strength

0.806
  1. Association of Prediagnostic Frailty, Change in Frailty Status, and Mortality After Cancer Diagnosis in the Women's Health Initiative. JAMA Netw Open. 2020 09 01; 3(9):e2016747.
    View in: PubMed
    Score: 0.156
  2. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer. Cancer. 2017 Jul 01; 123(13):2535-2542.
    View in: PubMed
    Score: 0.123
  3. Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1115-25.
    View in: PubMed
    Score: 0.088
  4. Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst. 2010 Oct 06; 102(19):1468-77.
    View in: PubMed
    Score: 0.078
  5. Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat. 2010 Aug; 122(3):859-65.
    View in: PubMed
    Score: 0.075
  6. Life After Cancer Epidemiology (LACE) Study: a cohort of early stage breast cancer survivors (United States). Cancer Causes Control. 2005 Jun; 16(5):545-56.
    View in: PubMed
    Score: 0.054
  7. Association of Low Muscle Mass and Low Muscle Radiodensity With Morbidity and Mortality for Colon Cancer Surgery. JAMA Surg. 2020 10 01; 155(10):942-949.
    View in: PubMed
    Score: 0.039
  8. An Environmental Scan of Biopsychosocial and Clinical Variables in Cohort Studies of Cancer Survivors. Cancer Epidemiol Biomarkers Prev. 2019 10; 28(10):1621-1641.
    View in: PubMed
    Score: 0.036
  9. Effect of depression before breast cancer diagnosis on mortality among postmenopausal women. Cancer. 2017 Aug 15; 123(16):3107-3115.
    View in: PubMed
    Score: 0.031
  10. The Effect of Patient and Contextual Characteristics on Racial/Ethnic Disparity in Breast Cancer Mortality. Cancer Epidemiol Biomarkers Prev. 2016 07; 25(7):1064-72.
    View in: PubMed
    Score: 0.029
  11. Impact of very low physical activity, BMI, and comorbidities on mortality among breast cancer survivors. Breast Cancer Res Treat. 2016 Feb; 155(3):551-7.
    View in: PubMed
    Score: 0.028
  12. Validation of self-reported comorbidity status of breast cancer patients with medical records: the California Breast Cancer Survivorship Consortium (CBCSC). Cancer Causes Control. 2016 Mar; 27(3):391-401.
    View in: PubMed
    Score: 0.028
  13. Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC). Cancer Epidemiol Biomarkers Prev. 2015 Feb; 24(2):361-8.
    View in: PubMed
    Score: 0.026
  14. Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative. Am Heart J. 2006 Jul; 152(1):170-6.
    View in: PubMed
    Score: 0.015

© 2024 Kaiser Permanente